Skip to Content
Next-gen-pharma-lab-Web-Banner-2880X1800-px
Solution

Next-gen laboratories solutions

To accelerate drug discovery, increase approval rates and reduce cycle times

Our Next-Gen laboratories solutions is not about wiping the slate clean. It’s a process that aligns the strategies of your organization with the needs of your IT professionals and researchers.

Together, we’ll look at the big picture, including your organization’s strategic goals, your research needs today and in the future, budgets, new technologies and more. We’ll consider your entire laboratory network to help prioritize each lab’s goals, aligning their work with each other, and with your overarching strategy. And we’ll go into the details, down to the ergonomics of your lab setup.

Your lab, your vision

The journey from molecule to medicine is central to advancing human health, but drug development is facing critical challenges – and those challenges are growing.

  • Global R&D costs have risen 45% over the past eight years
  • The average drug development lifecycle lasts twelve years
  • And only 10% of drugs that pass phase I trials make it to market

Fortunately, new technologies and innovative strategies make it possible to not only meet these challenges, but to help make your laboratories simpler, more efficient, and more powerful than ever. There’s no one-size-fits-all: our goal is to help you design your lab – with your teams’ personal preferences and individual needs – upgraded for the digital age.

Designing a Next-Gen laboratory that meets your needs

30 years ago, a lab was built. It was designed for one purpose, and it met that purpose well. As time passed, new employees came, and with them came new techniques and ways of working. One day word came down from above – the focus of their research was shifting. More equipment was brought in; older tools were put aside. When the lab was bought by a new owner, more equipment was swapped out, new furniture came in, and new methods were implemented. Today, like an old home, the lab bears the marks of years and years of alterations. It’s not the most efficient lab, but the people who work there feel comfortable in it. So why change anything?

Many laboratories today are facing challenges that limit their potential:

  • They lack a holistic approach, lowering efficiency and raising costs.
  • They’re less ready to adopt new technologies, slowing cycle times and approval and raising costs.
  • They’re creating data, but not realizing its full value, thus missing important insights, slowing approval and cycle times, and again, raising costs.
  • Organizational culture, skill management and workloads all suffer. For example, highly skilled researchers often spend a disproportionate time on low-value tasks. The result? Slower cycle times, higher costs, lower workplace satisfaction, and less innovation.

Laboratories need a new design: one that addresses the different needs of researchers, IT professionals, and business priorities.

Building the next-gen pharma lab

Cutting-edge laboratories are driving innovation andcompetitiveness within the pharmaceutical industry

Strategy, technology and service

Here’s some of what you can expect:

  • An integrated, living blueprint with a tailored set of tools that enable your labs to be continually redesigned and upgraded
  • A wide range of technology and process solutions that connect workflows, optimize them, and accelerate scaling
  • NextGen analytics, data science and reporting capabilities that speed up insights
  • A service ecosystem that offloads select processes to partners, letting scientists focus on what they do best

The lab of the future won’t appear out of thin air. It will be the result of years of your experience, our capabilities, and a clear focus on strategic thinking.

The result: A Next-Gen laboratory that support everyone’s goals

Your Next-Gen Laboratory is designed to support the goals of everyone involved: optimizing costs, improving approval, and minimizing cycle times. Here’s the result:

Optimized costs:

  • Scientists, technicians and lab managers will be able to focus on science, rather than managing suppliers, or trouble-shooting instruments. They’ll better anticipate tasks and plan their days accordingly.
  • Leaders of R&D, quality, tech, procurement and CxOs will optimize drug pipelines and improve ROI. Streamlined procurement will improve the process and lower the cost.

Improved approval:

  • Scientists, technicians and lab managers will be able to quickly review data and experimental research. More automated analysis will improve confidence in results.
  • Leaders of R&D, quality, tech, procurement and CxOs will quickly get an overview of their labs’ performance. They’ll be able to better leverage data to generate new insights.

Reduced cycle times:

  • Scientists, technicians and lab managers will be at the center of an optimized, intelligent network, with seamless access to past results and experiments.
  • Organizations will be able to convey information simply and smoothly from R&D labs all the way to commercial labs. Ultimately, they will reduce the time it takes to launch new drugs.

Our Next-Gen Laboratories Solutions bring your capabilities up to the limit of what’s technologically possible today. And this in turn brings your patients access to quality, safe and state-of-the-art treatment options, advancing human health one step further.

Getting started

Research laboratories are a triumph of the age, responsible for the greatest flourishing of human health the world has known. At the same time, the labs that brought you where you are today are not well equipped to take you to tomorrow. There’s unnecessary friction within workspaces. Talented scientists lose time on manual, peripheral tasks. And the deluge of data, often siloed, hampers intelligence and collaboration.

It’s time to take a fresh look at the heart of the research industry. Let’s build laboratories for the next generation of drug discovery.

Contact one of our experts and find out how NextGen Laboratories can help you advance the limits of human health.

Meet our experts

Brian Eden

Vice President, Global Life Sciences Technical Operations Leader, Capgemini

Amit Kakatkar

Director | SME & Lead – Lab of the Future, Life Sciences Industry Platform
Amit has been part of the Life Sciences industry for over 22 years. Amit completed a BSc, MSc, DIRI from the University Department of Chemical Technologies (UDCT), and an MBA from Newcastle University. Amit began their career as a Junior Scientific Officer at IRMRA, a joint affiliation between the Ministry of Defense and the Ministry of Commerce. Amit conducted extensive research on reverse engineering aspects of polymer compounding, involving separation techniques like HPLC and FTIR. In June 2007, Amit published their first paper in Rubber India on FTIR and its implications.

Matthew Thompson

Managing Consultant
Matthew Thompson has been working in various roles and industries in the life science sector for the past 20 years.  His consistent focus has always been on the laboratory, whether as a technician, research scientist or now as strategist focusing on transforming the laboratory for next generation of discoveries.  Matthew received a Ph.D in biochemistry and continued his work in the field of immune-oncology and worked as an analytical R&D scientist.  Since joining the consulting industry 7 years ago Matthew has focused on digital lab transformation efforts such as LIMS/ELN implementations, ERP integrations, global process harmonization, and digital strategy development.  Outside of the lab Matthew spends his time with his wife and 2 children outside of Chicago, Illinois.

Justin Melnick

R&D Transformation Partner Life Sciences
Justin leads Capgemini’s R&D for life sciences offer and is focused on the translatory role between the worlds of computational and biological sciences. He has 12 years experience in figuring out how to utilize technology to fundamentally impact human lives. A firm believer in tech-for-good and energized by the opportunity and ability to utilize technology in new ways that rewrite the business models of the life sciences world.